Sofie Derijcke
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 2
- Cancer-related cognitive impairment studies 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Cancer survivorship and care 2
- Co-authors
- Johan Vansteenkiste (2 shared papers)Veerle F.M. Surmont (2 shared papers)Philippe L. Vergauwe (4 shared papers)Hans Pottel (3 shared papers)Annelies Janssens (2 shared papers)Philip R. Debruyne (4 shared papers)Jan P. van Meerbeeck (2 shared papers)Tom Boterberg (4 shared papers)
- Journals
- Annals of Oncology (2 papers)Clinical Lung Cancer (2 papers)Psycho-Oncology (1 paper)Respiratory Medicine (1 paper)Lung Cancer (1 paper)
- Partner nations
- BelgiumUnited KingdomSwitzerland
In The Last Decade
Sofie Derijcke
18 papers receiving 728 citations
Sofie Derijcke's Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 407
- Pulmonary and Respiratory Medicine 360
- Geriatrics and Gerontology 10
- Cancer Research 26
- Internal Medicine 4
Countries citing papers authored by Sofie Derijcke
This map shows the geographic impact of Sofie Derijcke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Derijcke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Derijcke more than expected).
Fields of papers citing papers by Sofie Derijcke
This network shows the impact of papers produced by Sofie Derijcke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Derijcke. The network helps show where Sofie Derijcke may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofie Derijcke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study Hit paper breakdown → | 2018 | 498 |
| 2 | 2022 | 77 | |
| 3 | 2017 | 41 | |
| 4 | 2020 | 25 | |
| 5 | 2014 | 22 | |
| 6 | 2018 | 18 | |
| 7 | 2017 | 15 | |
| 8 | 2017 | 11 | |
| 9 | 2010 | 5 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2022 | 4 | |
| 14 | Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma | 2009 | 1 |
| 15 | 2013 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 0 |
About Sofie Derijcke
Sofie Derijcke is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Geriatrics and Gerontology and Conservation, having authored 19 papers that have together received 734 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer survivorship and care (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Immunotherapy and Immune Responses (2 papers), Hearing Loss and Rehabilitation (1 paper), Cancer-related cognitive impairment studies (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Oncology (407 citations), Pulmonary and Respiratory Medicine (360 citations), Geriatrics and Gerontology (10 citations), Cancer Research (26 citations) and Internal Medicine (4 citations). Sofie Derijcke has collaborated with scholars based in Belgium, United Kingdom and Switzerland. Frequent co-authors include Johan Vansteenkiste, Veerle F.M. Surmont, Philippe L. Vergauwe, Hans Pottel, Annelies Janssens, Philip R. Debruyne, Jan P. van Meerbeeck, Tom Boterberg, Koen Van Eygen and D. Galdermans. Their work appears in journals such as Annals of Oncology, Clinical Lung Cancer, Psycho-Oncology, Respiratory Medicine and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.